Ling Cheng

433 total citations
24 papers, 328 citations indexed

About

Ling Cheng is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Ling Cheng has authored 24 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Cancer Research and 3 papers in Surgery. Recurrent topics in Ling Cheng's work include MicroRNA in disease regulation (5 papers), RNA modifications and cancer (5 papers) and Cancer-related gene regulation (4 papers). Ling Cheng is often cited by papers focused on MicroRNA in disease regulation (5 papers), RNA modifications and cancer (5 papers) and Cancer-related gene regulation (4 papers). Ling Cheng collaborates with scholars based in China, Canada and United States. Ling Cheng's co-authors include Liangru Zhu, Jinfang Zhao, Hudan Liu, Kaifang Zou, Jun Yang, Yufeng Hu, Guoliang Qing, Libing Wang, Xiaohua Hou and Xiaojing Liu and has published in prestigious journals such as Cancer Research, Brain Research and Experimental Cell Research.

In The Last Decade

Ling Cheng

20 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ling Cheng China 12 175 78 50 41 39 24 328
Yunmin Lu China 11 211 1.2× 77 1.0× 56 1.1× 25 0.6× 28 0.7× 14 339
Zhenlei Wang China 11 174 1.0× 117 1.5× 54 1.1× 38 0.9× 16 0.4× 50 375
Shufang Liang China 11 189 1.1× 96 1.2× 44 0.9× 34 0.8× 12 0.3× 17 313
Marilena Castelli Italy 14 229 1.3× 88 1.1× 83 1.7× 53 1.3× 23 0.6× 23 413
Haiyang Li China 13 223 1.3× 140 1.8× 42 0.8× 33 0.8× 18 0.5× 41 411
Marwa Kamel Egypt 12 137 0.8× 65 0.8× 64 1.3× 19 0.5× 81 2.1× 21 384
Eman Khairy Egypt 12 158 0.9× 82 1.1× 36 0.7× 26 0.6× 13 0.3× 25 340
Jai-Nien Tung Taiwan 10 186 1.1× 62 0.8× 44 0.9× 35 0.9× 39 1.0× 11 340

Countries citing papers authored by Ling Cheng

Since Specialization
Citations

This map shows the geographic impact of Ling Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Cheng more than expected).

Fields of papers citing papers by Ling Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Cheng. The network helps show where Ling Cheng may publish in the future.

Co-authorship network of co-authors of Ling Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Ling Cheng. A scholar is included among the top collaborators of Ling Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Cheng. Ling Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Mingrui, Ling Cheng, Sisi Yang, & Yan Zhang. (2025). Physical activity, Vitamin D, and all-cause/cardiovascular mortality: a prospective study in older Chinese adults. BMC Geriatrics. 25(1). 38–38. 1 indexed citations
2.
Bao, Xueying, Dongren Yang, Ruoyun Wang, et al.. (2025). eCBT-I dialogue system: a comparative evaluation of large language models and adaptation strategies for insomnia treatment. Journal of Translational Medicine. 23(1). 862–862.
3.
4.
5.
Hu, Xudong, Bing Luo, Qing Wu, et al.. (2021). Effects of Dezocine and Sufentanil on Th1/Th2 Balance in Breast Cancer Patients Undergoing Surgery. Drug Design Development and Therapy. Volume 15. 4925–4938. 10 indexed citations
6.
Zhang, Jun, Xudong Jiang, Ling Cheng, et al.. (2021). Sequential use of EGFR-tyrosine kinase inhibitors based upon EGFR mutation evolution achieves long-term control in a non-small cell lung cancer patient: a case report. Annals of Palliative Medicine. 10(6). 7051–7056. 1 indexed citations
7.
Li, Jun, Yuyan Zhang, Kun Zhang, et al.. (2021). MiR-433-3p restrains the proliferation, migration and invasion of glioma cells via targeting SMC4. Brain Research. 1767. 147563–147563. 17 indexed citations
8.
Wang, Libing, et al.. (2021). MiR-452-5p Mediates the Proliferation, Migration and Invasion of Hepatocellular Carcinoma Cells Via Targeting COLEC10. Personalized Medicine. 18(2). 97–106. 16 indexed citations
9.
Zhou, Mi, Ling Cheng, Xing Chen, et al.. (2021). Loss of MBD2 attenuates MLL-AF9-driven leukemogenesis by suppressing the leukemic cell cycle via CDKN1C. Oncogenesis. 10(11). 79–79. 9 indexed citations
10.
Cheng, Ling, et al.. (2020). <p><em>miR-141</em> Promotes Colon Cancer Cell Proliferation by Targeted <em>PHLPP2</em> Expression Inhibitionn</p>. Cancer Management and Research. Volume 12. 11341–11350. 12 indexed citations
11.
Wang, Libing, et al.. (2020). miR-9-5p facilitates hepatocellular carcinoma cell proliferation, migration and invasion by targeting ESR1. Molecular and Cellular Biochemistry. 476(2). 575–583. 34 indexed citations
12.
Cheng, Ling, Xing Chen, Jing Zhou, et al.. (2020). Loss of MBD2 affects early T cell development by inhibiting the WNT signaling pathway. Experimental Cell Research. 398(1). 112400–112400. 9 indexed citations
13.
Liu, Xiaojing, Ling Cheng, Gengqing Song, et al.. (2019). Estrogen receptor β activation ameliorates DSS-induced chronic colitis by inhibiting inflammation and promoting Treg differentiation. International Immunopharmacology. 77. 105971–105971. 38 indexed citations
14.
Zhou, Mi, Ling Cheng, Xing Chen, et al.. (2018). MBD2 Ablation Impairs Lymphopoiesis and Impedes Progression and Maintenance of T-ALL. Cancer Research. 78(7). 1632–1642. 15 indexed citations
15.
16.
Cheng, Ling, et al.. (2017). Inferior mesenteric arteriovenous fistula with nonpulsatile abdominal mass. Medicine. 96(48). e8717–e8717. 7 indexed citations
17.
Zhao, Jinfang, et al.. (2016). Cronkhite-Canada syndrome: a rare case report and literature review. BMC Gastroenterology. 16(1). 23–23. 15 indexed citations
18.
Liu, Lin, et al.. (2016). Anti-inflammatory properties of lipoxin A4 protect against diabetes mellitus complicated by focal cerebral ischemia/reperfusion injury. Neural Regeneration Research. 11(4). 636–636. 11 indexed citations
19.
Hu, Yufeng, Hexiu Su, Xu Li, et al.. (2014). The NOTCH Ligand JAGGED2 Promotes Pancreatic Cancer Metastasis Independent of NOTCH Signaling Activation. Molecular Cancer Therapeutics. 14(1). 289–297. 26 indexed citations
20.
Yao, Guangmin, Guanqun Zhan, Yufeng Hu, et al.. (2014). N-methylhemeanthidine chloride, a novel Amaryllidaceae alkaloid, inhibits pancreatic cancer cell proliferation via down-regulating AKT activation. Toxicology and Applied Pharmacology. 280(3). 475–483. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yunmin Lu Breakdown of academic impact, for papers by Zhenlei Wang Breakdown of academic impact, for papers by Shufang Liang Breakdown of academic impact, for papers by Marilena Castelli Breakdown of academic impact, for papers by Haiyang Li Breakdown of academic impact, for papers by Marwa Kamel Breakdown of academic impact, for papers by Eman Khairy Breakdown of academic impact, for papers by Jai-Nien Tung
Rankless by CCL
2026